SCHEMBL14860804

SCHEMBL14860804

C[N+]1(CCCCC[N+]23CCC(CC2)C(O)C3)CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
APOBEC3A P31941 3/20 0.41
APOBEC3G Q9HC16 3/20 0.41
KMT2A Q03164 1/20 0.41
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
GNAI3 P08754 1/20 0.38
GNAO1 P09471 1/20 0.38
GNAI1 P63096 1/20 0.38
BBOX1 O75936 2/20 0.38
CTDSP1 Q9GZU7 1/20 0.35
CHKA P35790 1/20 0.34
FOXM1 Q08050 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL14863756 0.98 LMNA (0.40) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Water SCHEMBL14863753 0.98 LMNA (0.40) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Bromide SCHEMBL14914174 0.98 LMNA (0.40) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Bromide SCHEMBL14914176 0.98 LMNA (0.40) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
SCHEMBL14860448 0.98 LMNA (0.39) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Water SCHEMBL14861736 0.97 LMNA (0.38) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Bromide SCHEMBL14861641 0.97 LMNA (0.38) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Water SCHEMBL14863351 0.97 LMNA (0.38) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
Bromide SCHEMBL14861643 0.97 LMNA (0.38) LMNAAPOBEC3AAPOBEC3GKMT2ACYP3A4
SCHEMBL4546743 0.85 CHKA (0.41) APOBEC3AAPOBEC3GCHKACHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP claimed
US-20160102590-A1 METHODS OF MAKING POROUS CRYSTALLINE MATERIALS AND THEIR USE IN HYDROCARBON SORPTION EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-04-14 US claimed
US-9035058-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-05-19 US claimed
US-20150087841-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-03-26 US claimed
US-8916130-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2014-12-23 US claimed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US claimed
WO-2022085774-A1 HYDROCARBON ADSORBENT AND HYDROCARBON ADSORPTION METHOD 東ソー株式会社 2022-04-28 WO disclosed
US-10226319-B2 Removal of occluded alkali metal cations from MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING (US) 2019-03-12 US disclosed
US-20180161139-A1 REMOVAL OF OCCLUDED ALKALI METAL CATIONS FROM MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-06-14 US disclosed
US-9896344-B2 Removal of occluded alkali metal cations from MSE-framework type molecular sieves EXXONMOBILE RESEARCH AND ENGINEERING COMPANY (US) 2018-02-20 US disclosed
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP disclosed
EP-2766303-B1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RES & ENG CO (US) 2017-11-22 EP disclosed
EP-3206785-A1 REMOVAL OF OCCLUDED ALKALI METAL CATIONS FROM MSE-FRAMEWORK TYPE MOLECULAR SIEVES Exxonmobil Research And Engineering Company (US) 2017-08-23 EP disclosed
EP-2766303-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES ExxonMobil Research and Engineering Company (US) 2014-08-20 EP disclosed
EP-2766303-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES ExxonMobil Research and Engineering Company (US) 2014-08-20 EP disclosed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US disclosed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US disclosed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US disclosed
WO-2013055871-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-04-18 WO disclosed
WO-2013055871-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087841-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, B2M, UFM1 LMNA 3785/4885APOBEC3A 4518/4885APOBEC3G 4254/4885
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, UFM1, B2M LMNA 3760/4885APOBEC3A 4483/4885APOBEC3G 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.